VR Logo

Cel-Sci Corporation (CVM) download report


Healthcare | Biotechnology & Pharma Research

Cel-Sci Corporation (CVM) Premium Coverage

53 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases.

IPO Date: 01-Jan-1987

Chief Exec. & Financial Officer, Treasurer and Director: Mr. Geert R. Kersten Esq.

Sr. VP of Operations & Corp. Sec.: Ms. Patricia B. Prichep

Listing: NYSE: CVM

Country: United States

Headquarters: Vienna, VA

Website: https://cel-sci.com

Key Facts

Market cap: $182.41 Mln

Revenue (TTM): $0.00 Mln

Earnings (TTM): $-36.01 Mln

Cash: $34.28 Mln

Total Debt: $16.05 Mln

Insider's Holding: 3.90%

Liquidity: Low

52 Week range: $2.50 - 12.90

Shares outstanding: 43,328,100

10 Years Aggregate:

  • CFO: $-142.36 Mln
  • EBITDA: $-241.66 Mln
  • Net Profit: $-233.11 Mln

Stock Performance

Time Period Cel-Sci (CVM) S&P BSE Sensex S&P Small-Cap 600
YTD-41.272.08-8.13
1 month-6.929.3214.13
3 months61.639.9412.23
1 Year-53.259.05-5.78
3 Years-20.0216.5311.43
5 Years12.5413.769.16
10 Years-26.0512.9711.05
As on 12-Aug-2022
Year Cel-Sci (CVM) S&P Small-Cap 600 S&P BSE Sensex
2021-39.1125.2721.99
202027.439.5715.75
2019218.8220.8614.38
201851.52-9.705.87
201712.4911.7327.91
2016-81.8424.741.95
2015-36.32-3.36-5.03